SALIXIN A/S: Financial statements 2013
CVR: 33776748
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
SALIXIN A/S (CVR 33776748) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -25,807 and a net result of DKK -487,490. Equity in the 2013 report amounted to DKK -92,797.
- Gross Profit
- DKK -25,807
- Profit/Loss
- DKK -487,490
- Equity
- DKK -92,797
- Total Assets
- DKK 904,253
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
SALIXIN A/S has published its interim report for the period July 1, 2011 – December 31, 2012.
As of June 4, 2013, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of SALIXIN A/S.
About SALIXIN A/S
SALIXIN A/S is a Danish company of the type Aktieselskab based in Tylstrup, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Allan Juul Bech. The board consists of Michael Bundgaard (chair), Allan Juul Bech and Louise Bech. The company is owned by Ny Vraa A/S. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 169,447 and a net result of DKK 106,174 compared with DKK 1,051,659 the year before. Equity in the 2025 report amounted to DKK 124,343.